R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group
暂无分享,去创建一个
E. González-Barca | J. Sancho | N. Gutiérrez | M. Fuertes | J. Moraleda | M. Sorigué | C. Grande | F. Peñalver | Alejandro Martín | A. Batlle-López | J. Hernández‐Rivas | O. García | J. Guinea | F. Gual-Capllonch | E. Gimeno | M. Penarrubia | R. Fernández-Álvarez | Esther González-García | M. Bastos | E. González-García